Strontium ranelate for the treatment of osteoporosis
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7505.1400 (Published 16 June 2005) Cite this as: BMJ 2005;330:1400All rapid responses
Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
In my neck of the woods - the south-west peninsula of the UK - the
current wait for bone mineral densitometry (DEXA scanning)is somewhere in
the region of 18 months. The thought that this very scarce resource might
now be used in part to check on compliance with treatment of patients
taking strontium is depressing. The latest NICE guidelines more or less
insist that anti-osteoporotic treatments shouldn't be started without DEXA
scans, so the pressure is growing rapidly just for diagnostic purposes,
never mind follow-up scans to assess response to treatment or compliance.
There is a cheaper, simpler, and less harmful way of checking compliance:
first, check the computer records to see that prescriptions are being
issued; and second, fix the patient in the eye and ASK them!
Dougal Jeffries
Competing interests:
None declared
Competing interests: No competing interests
what is known on the effect of stontium ranelate
in patients whith glucocorticoid induced osteoporosis?
Competing interests:
None declared
Competing interests: No competing interests
Re: effect on glucocorticoid induced osteoporosis
There is no data on this topic.
Competing interests:
Consultant to Servier
Competing interests: No competing interests